Home > Financial Ratios > BIOCON

BIOCON
Fixed Capital/Sales

    Back to All Ratios
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Fixed Capital/Sales(x) 2.612.572.452.061.31

What is the latest Fixed Capital/Sales ratio of BIOCON ?

The latest Fixed Capital/Sales ratio of BIOCON is 2.61 based on Mar2026 Consolidated results.
Year Fixed Capital/Sales
Mar20262.61
Mar20252.57
Mar20242.45
Mar20232.06
Mar20221.31

How is Fixed Capital/Sales of BIOCON Trending?

Years Fixed Capital/Sales % Change
Mar2026 2.61
1.56
Mar2025 2.57
4.90
Mar2024 2.45
18.93
Mar2023 2.06
57.25
Mar2022 1.31 -

Other Financial Ratios of BIOCON


Compare Fixed Capital/Sales ratio of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹60,445.6 Cr -2.7% -7.6% 4.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹434,280.0 Cr -2.4% -6.2% 11.8% Stock Analytics
DIVIS LABORATORIES ₹246,737.0 Cr -3.3% 1.4% 57.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,129.0 Cr -4.5% -4% 35.9% Stock Analytics
CIPLA ₹108,808.0 Cr -3.6% -5% -10.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,170.0 Cr -0.2% 2.5% -3% Stock Analytics


BIOCON Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-2.7%

-7.6%

4.3%

SENSEX

-2.3%

-6.6%

-12%


You may also like the below Video Courses